🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Thank you to everyone who attended our annual meeting this year. We appreciate everyone’s support and efforts in our clinical trials and advancement in pediatric neuro-oncology.

Big news for the pediatric neuro-oncology community! Publications from @CBTNetwork and PNOC researchers are available in a special issue of Neoplasia! In honor of #BTAM, we'll be sharing articles throughout May. PNOC Foundation View here: buff.ly/3HQr8gv

Follow the link to read the full special issue and join us in shaping the future of care for children with brain tumors #PediatricNeuroOncology #ChildhoodCancer #OpenScience #Neoplasia #DMG #ATRT #Ependymoma #Medulloblastoma

An inspiring and beautiful song, indeed! Follow the link to read more on Marin Independent Journal about this: marinij.com/2023/05/07/mil…

Diffuse Midline Glioma (#DMG), including (#DIPG), is an aggressive tumor of the CNS with no known cure. To provide the best care for DMG patients, connecting early on with a specialized interdisciplinary team is crucial. buff.ly/42G41gQ PNOC PNOC Foundation #BTAM

New treatments for pediatric low-grade gliomas #pLGGs are offering hope for children with this #braintumor. Understanding the genetic changes that cause pLGGs have led to targeted therapies that were not possible before. #BTAM PNOC PNOC Foundation buff.ly/42GLAZm

#PNOC_kids is excited to present at #SNO2023 on the combination of ONC201+paxalisib in children & young adults with DMGs after completing RT. Preliminary results show that immediate OS significantly exceeds control data. Chimerix, Inc. Kazia Therapeutics ChadTough Defeat DIPG Foundation PNOC Foundation SNO

‼️ #SNO2023 simultaneous publication in #JCO by Mueller, et al: Everolimus for Children with Recurrent or Progressive Low-Grade Glioma: Results from the Phase 2 PNOC001 Trial. brnw.ch/21wEyjN

PNOC001, our Phase II Study of everolimus for recurrent or progressive low-grade gliomas in children is now published! A huge congratulations to the team! Read more at: ascopubs.org/doi/10.1200/JC…

Encouraging preliminary interim Overall Survival data for #PNOC022 was presented by Dr. Sabine Mueller at #SNO2023. Analyses continues and we look forward to begin enrolling new patients soon! Special THANKS to the patients and families who are participating in the study.

PNOC #ATRT group is advancing with our first trial for this critical patient group! Johns Hopkins' preclinical data strongly indicates efficacy of paxalisib with gemcitabine for #ATRT. Updates to follow! Eric H. Raabe, MD, PhD Kazia Therapeutics Tom Rosenberg Alyssa Reddy Ashley S Margol Susan Chi

It’s a privilege to be part of this incredible team of international PNOC researchers driven to cure #DIPG #DMG. Thank you Advanced Therapies for Pediatric Solid Tumors Lab & Clínica Universidad de Navarra for hosting us in Madrid and honored to represent Seattle Children's & the #VitanzaLab. Great progress & so much to do.

A very warm welcome from Boston to our phenomenal PNOC investigators as we kicked off our Spring Meeting🧠Time to dive into innovative research and collaborations driving pediatric neuro-oncology forward! #BostonBound

Good afternoon from Boston! Day 2 of our meeting at Dana-Farber starts with some exciting updates from our PNOC team and presentations by other brilliant investigators (Pictured: Ashley S Margol, Cassie Kline, MD, Aubrie Drechsler, Rebecca Ronsley, MD and Dr. Zeng-Jie Yang)

More from our meeting: Dr. Danielle Bitterman's (Harvard Medical) insightful talk on 'AI's Potential for Clinical Trials' has sparked exciting discussions as we explore the continued use of technology to transform research and patient outcomes💡 #AI #ClinicalTrials #Innovation

After elaborate discussions yesterday, Day 2 concluded with updates from our Working Groups. Grateful for their ongoing dedication in advancing PNOC's mission 🤝. For more info on our groups, click: pnoc.us/research-group… Pictured: APPNIC, DEI, DMG-ACT and Medulloblastoma WGs

Commencing #BrainTumorAwarenessMonth by gathering Pediatric Neuro-Oncology experts worldwide, with gratitude to Dana-Farber for hosting us! Appreciating all who joined, whether virtually or in person. Anticipating continued progress following a fruitful meeting! #BTAM #PNOC

PNOC is thrilled to announce that 15 of our study and working group abstracts have been accepted to #ISPNO2024! We are eager to attend and present these in the coming week. A big thank you to all our amazing collaborators!

Key highlights from #ISPNO2024 so far - Presentations from APPNIC WG, Dr. Cassie Kline (presenting PNOC026) and Dr. Sabine Mueller (presenting on international trials). Looking forward to the rest of our presentations!

PNOC is excited to collaborate with Children’s Brain Tumor Network on a transformative project awarded by ARPA-H. This project will revolutionize data integration & utilization to significantly enhance the treatment & care of children with brain tumors. pnoc.us/update/press-r…